A carregar...
Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
New post hoc analysis of IPF clinical trials suggests that treatment with pirfenidone slows the worsening of patient-reported breathlessness over 12 months versus placebo in patients with more advanced disease (GAP stage II/III or FVC <80%) http://bit.ly/2yJyUVT
Na minha lista:
| Publicado no: | Eur Respir J |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
European Respiratory Society
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6766683/ https://ncbi.nlm.nih.gov/pubmed/31164431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00399-2019 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|